SuperScript Publication Scavenger Hunt
Did you know SuperScript™ Reverse Transcriptase was first introduced more than 25 years ago? That’s right—with over 35,000 publications to date, SuperScript Reverse Transcriptase (RT) has been used to synthesize cDNA from a wide range of RNA templates, from tumor tissue to Ebola virus.
In celebration of the use of SuperScript RT as an invaluable tool for molecular biology research, we invite you to join us on a very cool publication scavenger hunt. If you can find qualifying publications on SuperScript RT, you can enter to win SuperScript RT for your lab!**
Every two months, we will highlight a selected application where SuperScript RT is used to synthesize cDNA. To join the hunt, find a publication relevant to the application and enter the citation using SuperScript RT. Up to 10 winners will be randomly drawn from the entries each month, and the winner can select to receive SuperScript VILO Master Mix or the new SuperScript IV First-Strand Synthesis System, 50 reactions. Very cool, indeed!
Let the hunt begin!
Skin cancer, the most common type of cancer, accounts for the majority of newly diagnosed cancer cases each year; more than the breast, prostate, lung and colon cancer cases combined, according to the Skin Cancer Foundation and the American Cancer Society, Cancer Facts and Figures 2015. The vast majority of skin cancer cases, referred to as keratinocyte carcinomas and melanomas, are fortunately very treatable when detected early. Research into causes, prevention and early treatment of skin cancer is being done throughout the world and RT-PCR represents one of the most common and important tests in cancer diagnosis. Here are some examples of publications citing the use of SuperScript RT in RT-PCR applications for the analysis and diagnosis of skin cancer.
- Aissaoui, H etal. (2015) MDA-9/Synthenin is Essential for Factor VIIa-induced Signaling, Migration, and Metastasis in Melanoma Cells. J.Biol. Chem. 290: 3333- 3348. RT-PCR using SuperScript II Reverse Transcriptase
- Romero A.I. etal (2014) Regulation of CD4+ NKG2D+ Th1 Cells in patients with metastatic melanoma treated with Sorafenib: role of IL-15Ra and NKG2D Triggering. Cancer Res. 74: 68-80. Total RNA isolated from melanoma cell, cDNA synthesized by SuperScript III Reverse Transcriptase followed by qPCR.
Terms and conditions:
**No purchase necessary to enter or win. The SuperScript Reverse Transcriptase for cDNA Synthesis Publication Scavenger Hunt Sweepstakes (the “Sweepstakes”) is only open to life science professionals 21 years and older in the US (excluding Puerto Rico) and Canada (excluding Quebec) who submit a completed entry form available at lifetechnologies.com/sspublication. The Sweepstakes begins on June 1, 2015. The last opportunity to submit an entry form is December 31, 2015 at 11:59 p.m. US Pacific Time in order to be eligible for a chance to win either a SuperScript VILO™ Master Mix (approximate retail of $488 USD) or SuperScript IV First Strand Synthesis System (approximate retail value of $443 USD). There will be a random drawing held on the 15th day of the month starting on July 15, 2015 and ending on January 15, 2016. Ten winners will be selected at each drawing. Healthcare Professionals (term defined in the complete terms and conditions) may not participate in this promotion. Limit one entry per person. Odds of winning depend on the number of eligible entries received. By submitting your entry, you warrant that you are not prohibited by employment, contract, or law from accepting a prize from the Sponsor. Offer void where prohibited, licensed, or restricted by federal, state, provincial, or local laws, regulations, or agency/institutional policies. Other restrictions may apply. A copy of the complete Terms and Conditions is available online here.